Last reviewed · How we verify
rh-GCSF
At a glance
| Generic name | rh-GCSF |
|---|---|
| Also known as | Granulocyte colony stimulating factor,neubogen,filgstrim |
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy (PHASE1)
- A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy. (PHASE2)
- Effect of Recombinant Human Granulocyte Colony- Stimulating Factor on CD11b in Septic Neonates (PHASE4)
- Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |